Skip to main content

Cormorant Asset Management, LP

Position in BBOT — BridgeBio Oncology Therapeutics, Inc.

CIK 1583977 BOSTON, MA

Position in BBOT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$136,234,886
-$23,778,530 QoQ
Shares Held
17,878,594
0.0% QoQ
Ownership
22.3%
of shares outstanding
% of Portfolio
6.92%
of 13F equity value
Holder Rank
#1
of 66 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBOT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. BBOT ranks #2 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BBOT
BridgeBio Oncology Therapeutics, Inc.
This page
17,878,594 $136,234,886

All Filings in BBOT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $136,234,886 17,878,594
2026-03-31 $160,013,416 17,878,594
2025-12-31 $223,839,996 17,878,594
2025-09-30 $207,034,118 17,878,594
2025-06-30 HLXB 2,909,000
2025-03-31 HLXB 2,909,000
2024-12-31 HLXB 2,909,000
2024-09-30 HLXB 2,909,000
2024-06-30 HLXB 2,909,000
2024-03-31 HLXB 2,909,000